GLP-3 GLP-1/GIP/Glucagon Triple Receptor Agonist

Description

Overview A triple-pathway incretin peptide supplied as lyophilized powder in sealed vial format. Available at 14mg and 28mg. Supplied for controlled in vitro work by qualified laboratory personnel.

Research Background & Mechanistic Focus The most structurally complex of the three incretin arms in this catalog, engaging GLP-1, GIP and glucagon receptors from a single peptide backbone. Research focus sits on receptor balance, meaning the relative potency at each of the three targets and how shifting that balance changes the overall signaling signature. Laboratory work commonly involves three-way selectivity profiling, competitive binding assays run against each receptor population separately, and comparative modeling against the single and dual pathway arms. Analytical characterization is more demanding than the simpler analogues owing to the tri-agonist structure.

Structural Information Classification: Triple-pathway incretin research peptide Form: Lyophilized vial presentation Catalog Strengths: 14mg, 28mg  

Research Applications Used in controlled laboratory settings for receptor-signaling models, comparative pathway analysis, presentation or stability work where applicable, and other non-clinical analytical workflows consistent with authorized research use.  

Specifications Research-grade material supplied in lyophilized vial presentation at selected catalog variants. Intended for controlled laboratory handling and analytical preparation only.  

Handling & Use Conditions Allow the vial to equilibrate before opening. Reconstitute only under controlled laboratory conditions using appropriate technique. Avoid vigorous agitation, repeated freeze-thaw exposure, and unnecessary environmental exposure during handling.  

Storage & Stability Store refrigerated or frozen according to laboratory protocol, protected from light and repeated freeze-thaw cycling. Reconstituted material should be stored only under controlled conditions appropriate for short-term analytical use.  

Sourcing Statement RawBiotix research compounds are sourced through U.S.-based supply and verified through independent analytical testing. Minimum 98% purity. Certificates of Analysis available upon request.  

Disclaimer For laboratory research use only. Not for human consumption, therapeutic, or diagnostic purposes.